Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  Sun Pharmaceutical Industries Limited    SUNPHARMA   INE044A01036

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
08/17/2017 08/18/2017 08/21/2017 08/22/2017 08/23/2017 Date
489(c) 470.45(c) 460.05(c) 472(c) 468.5(c) Last
4 484 873 4 513 543 4 215 469 3 797 497 3 682 870 Volume
+0.68% -3.79% -2.21% +2.60% -0.74% Change
More quotes
Financials ( INR)
Sales 2018 286 696 M
EBIT 2018 52 115 M
Net income 2018 35 351 M
Finance 2018 128 289 M
Yield 2018 0,64%
Sales 2019 321 658 M
EBIT 2019 67 957 M
Net income 2019 55 076 M
Finance 2019 157 025 M
Yield 2019 0,79%
P/E ratio 2018 28,07
P/E ratio 2019 20,40
EV / Sales2018 3,49x
EV / Sales2019 3,02x
Capitalization 1 128 754 M
More Financials
Company
Sun Pharmaceutical Industries Ltd. engages in development, manufacturing, sell, trading, marketing and export of various pharmaceutical products.The company produces generic products targeting spectrum of chronic and acute treatments.It manufactures span generics, branded generics,... 
Sector
Pharmaceuticals
Calendar
11/09Earnings Release
More about the company
Surperformance© ratings of Sun Pharmaceutical Industr
Trading Rating : Investor Rating :
More Ratings
Latest news on SUN PHARMACEUTICAL INDUSTR
08/17 SUN PHARMACEUTICAL INDUSTRIES : Researchers Submit Patent Application, "Parenter..
08/16 SUN PHARMACEUTICAL INDUSTRIES : Pharma receives amalgamation order from NCLT
08/14 SUN PHARMACEUTICAL INDUSTRIES : Pharma concludes acquisition of stakes in Krysta..
08/14 SUN PHARMACEUTICAL INDUSTRIES : Pharma concludes acquisition of stakes in Krysta..
08/14 SUN PHARMACEUTICAL INDUSTRIES : Pharma declines over 3.5% on weak earnings
08/12 SUN PHARMACEUTICAL INDUSTRIES : Pharma settles insider trading case
08/12 SUN PHARMACEUTICAL INDUSTRIES : POSTS Rs424-CR LOSS ON WEAK SALES, ANTITRUST SET..
08/12 SUN PHARMACEUTICAL INDUSTRIES : PHARMA Q1 NET LOSS AT Rs424.92 CRORE
08/11 SUN PHARMACEUTICAL INDUSTRIES : FY18 Q1 Financial Press Release
08/10 SUN PHARMACEUTICAL INDUSTRIES : An Application for the Trademark "BELKIMA" Has B..
More news
Sector news : Generic Pharmaceuticals
11:18a FTSE 100 flat as WPP sinks
08:48aDJBAYER : Big Move Triggers 'Doubts' -- WSJ
08/22 JOHNSON & JOHNSON : Massive California verdict expands J&J's talc battlefield
08/22 JOHNSON & JOHNSON : Massive California verdict expands J&J's talc battlefield
08/22DJBAYER : Monsanto's $57 Billion Megadeal Faces Closer EU Scrutiny -- 2nd Update
More sector news : Generic Pharmaceuticals
Latest Tweets
10:39aBessemer Group Inc. Has $234,000 Stake in Taro Pharmaceutical Industries Ltd... 
08/19Taro Pharmaceutical Industries Ltd. $TARO Given Consensus Rating of “” by Bro.. 
08/11Concordia International Corp. $CXRX and Taro Pharmaceutical Industries $TARO .. 
08/11Taro Pharmaceutical Industries Ltd. $TARO Stock Rating Lowered by BidaskClub .. 
08/11Taro Pharmaceutical Industries Ltd. $TARO Rating Lowered to C+ at TheStreet  
More tweets
Qtime:60
Chart SUN PHARMACEUTICAL INDUSTR
Duration : Period :
Sun Pharmaceutical Industr Technical Analysis Chart | SUNPHARMA | INE044A01036 | 4-Traders
Technical analysis trends SUN PHARMACEUTICAL INDUSTR
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 38
Average target price 505  INR
Spread / Average Target 7,3%
EPS Revisions
Managers
NameTitle
Dilip Shantilal Shanghvi Managing Director & Executive Director
Israel Makov Chairman
Uday Vijaykumar Baldota Chief Financial Officer
Govind K. Jaju President & Global Head-Technical Operations
Rajamannar Thennati Head-Research & Development
Sector and Competitors